In 2024, PolyPeptide made substantial progress in restoring profitability. The gross profit for 2024 was EUR 39.3 million versus EUR 9.1 million in 2023, and EBITDA was EUR 25.4 million versus EUR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback